OncoLink Cancer Treatment and Resources

Radiation after radical hysterectomy for cervical cancer

Last Modified: May 31, 2003

Question

Dear OncoLink "Ask The Experts,"
After undergoing a radical hysterectomy with the removal of lymph nodes and ligaments for cervical cancer with no evidence of spread, I am now faced with the possibility of 6 weeks of radiation therapy. This therapy has been recommended because of the position of the tumor (3 mm from the cervical wall). I am hesitant to put my body through this treatment. Can you suggest other methods/tests to closely monitor the pelvic area for recurrence of disease?  

Answer

Christina S. Chu, MD, Assistant Professor of the Division of Gynecologic Oncology at the University of Pennsylvania Health System, responds:

After radical hysterectomy for cervical cancer, some patients are at higher risk for recurrence of cancer. For example, patients with large tumors (more than 4 cm in size), positive lymph nodes, deep invasion into the tissue of the cervix, or invasion into the small blood or lymphatic vessels, may put patients at higher risk for recurrence even though there is no gross evidence of tumor present after the surgery. I do not know all of the details of your case, but I assume that your physicians are recommending additional radiation because of the closeness of the tumor to the margin of tumor removal. They are recommending radiation to try to decrease your risk of having tumor recurrence. You should be aware that patients who do not have clear evidence of tumor in their body after surgery may still develop recurrence. The only methods in routine use for detecting disease recurrence include physical examination, Pap testing of the upper vagina, CT scan, and MRI. PET scan is another promising option, but the test has not yet been fully validated to detect recurrence of cervical cancer. You must understand that it is much easier to prevent a recurrence of cancer with radiation therapy then to treat a recurrence once it occurs. Overall, radiation therapy is tolerated well, and you should have additional discussions with your gynecologic oncologist and radiation oncologist regarding your concerns.

OncoLink I wish u knew...

Ms. Bruning talks about working in development for a cancer center and how this translates to hope in cancer care. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy

Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS